Document is current

Any future updates will be listed below

Correction to: Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML

Crossref DOI link: https://doi.org/10.1038/s41420-021-00558-1

Published Online: 2021-07-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark